Mayburd AL - Search Results

1

Ingenuity network-assisted transcription profiling: Identification of a new pharmacologic mechanism for MK886.

Mayburd AL, Martlínez A, Sackett D, Liu H, Shih J, Tauler J, Avis I, Mulshine JL. Mayburd AL, et al. Clin Cancer Res. 2006 Mar 15;12(6):1820-7. doi: 10.1158/1078-0432.CCR-05-2149. Clin Cancer Res. 2006. PMID: 16551867

2

Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.

Avis I, Martínez A, Tauler J, Zudaire E, Mayburd A, Abu-Ghazaleh R, Ondrey F, Mulshine JL. Avis I, et al. Cancer Res. 2005 May 15;65(10):4181-90. doi: 10.1158/0008-5472.CAN-04-3441. Cancer Res. 2005. PMID: 15899809

3

Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets.

Mayburd AL, Golovchikova I, Mulshine JL. Mayburd AL, et al. Bioinformatics. 2008 Feb 1;24(3):389-95. doi: 10.1093/bioinformatics/btm447. Epub 2007 Oct 8. Bioinformatics. 2008. PMID: 17925305

4

Expression variation: its relevance to emergence of chronic disease and to therapy.

Mayburd AL. Mayburd AL. PLoS One. 2009 Jun 15;4(6):e5921. doi: 10.1371/journal.pone.0005921. PLoS One. 2009. PMID: 19526064 Free PMC article.

5

Influenza antiviral therapeutics.

Mayburd AL. Mayburd AL. Recent Pat Antiinfect Drug Discov. 2010 Jan;5(1):64-75. doi: 10.2174/157489110790112527. Recent Pat Antiinfect Drug Discov. 2010. PMID: 19929841 Review.

6

Patent landscape of countermeasures against smallpox and estimation of grant attraction capability through patent landscape data.

Mayburd AL, Kedia G, Evans HW, Kaslival PC. Mayburd AL, et al. Recent Pat Antiinfect Drug Discov. 2010 Nov;5(3):240-54. doi: 10.2174/157489110793348758. Recent Pat Antiinfect Drug Discov. 2010. PMID: 20738241 Review.

7

Predicting High-Impact Pharmacological Targets by Integrating Transcriptome and Text-Mining Features.

Mayburd A, Baranova A. Mayburd A, et al. J Pharm Pharm Sci. 2016 Oct-Dec;19(4):475-495. doi: 10.18433/J3SC8X. J Pharm Pharm Sci. 2016. PMID: 28057171 Free article.

8

Knowledge-Based Compact Disease Models: A Rapid Path from High-Throughput Data to Understanding Causative Mechanisms for a Complex Disease.

Mayburd A, Baranova A. Mayburd A, et al. Methods Mol Biol. 2017;1613:425-461. doi: 10.1007/978-1-4939-7027-8_17. Methods Mol Biol. 2017. PMID: 28849571

9

Increased lifespan, decreased mortality, and delayed cognitive decline in osteoarthritis.

Mayburd AL, Baranova A. Mayburd AL, et al. Sci Rep. 2019 Dec 9;9(1):18639. doi: 10.1038/s41598-019-54867-8. Sci Rep. 2019. PMID: 31819096 Free PMC article.

10

Pharmacological signatures of the reduced incidence and the progression of cognitive decline in ageing populations suggest the protective role of beneficial polypharmacy.

Mayburd AL, Koivogui M, Baranova A. Mayburd AL, et al. PLoS One. 2019 Nov 6;14(11):e0224315. doi: 10.1371/journal.pone.0224315. eCollection 2019. PLoS One. 2019. PMID: 31693707 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters